Labor drug pause may protect newborns

NCT ID NCT03991091

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether turning off the labor drug oxytocin once a woman reaches 6 cm dilation (active labor) could lower the chance of newborn complications. Over 2,400 women with a single, full-term baby in head-down position took part. The goal was to see if this simple change in drug timing could improve newborn health outcomes like breathing, blood acidity, and need for intensive care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL MORBIDITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • hospital Cochin; port royal Maternity unit

    Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.